CENTR Brands (TSE:CNTR)
:CNTR
Want to see TSE:CNTR full AI Analyst Report?
Top Page
CENTR Brands
(CNTR)
Select Model
Select Model
Rating:44Neutral
Price Target:
C$0.05
▲(145.00% Upside)
Action:Reiterated
Date:05/20/26
The score is primarily constrained by weak financial performance (zero reported revenue, ongoing losses, negative free cash flow, and deeply negative equity), which outweighs only modestly constructive technical signals. Valuation provides limited support because the company is unprofitable (negative P/E) and no dividend yield is available.
Positive Factors
Multi-channel distribution
CENTR’s business model sells via wholesale, retail and direct-to-consumer channels, which diversifies revenue routes and reduces reliance on any single partner. Over a 2-6 month horizon this multi-channel access supports durable market reach, faster SKU rollouts, and repeatable scaling as distribution expands.
Negative Factors
No reported revenue
Zero reported trailing revenue is a fundamental red flag: the core commercial model is not yet generating measurable sales, so product-market fit and distribution monetization remain unproven. Over months this leaves the company highly dependent on financing and execution to validate the business.
Read all positive and negative factors
Positive Factors
Negative Factors
Multi-channel distribution
CENTR’s business model sells via wholesale, retail and direct-to-consumer channels, which diversifies revenue routes and reduces reliance on any single partner. Over a 2-6 month horizon this multi-channel access supports durable market reach, faster SKU rollouts, and repeatable scaling as distribution expands.
Read all positive factors
CENTR Brands (CNTR) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$578.99K
Dividend YieldN/A
Average Volume (3M)17.60K
Price to Earnings (P/E)―
Beta (1Y)-2.46
Revenue GrowthN/A
EPS GrowthN/A
CountryCA
Employees18
SectorConsumer Defensive
Sector Strength42
IndustryDrug Manufacturers - Specialty & Generic
Share Statistics
EPS (TTM)-9.42
Shares Outstanding11,579,740
10 Day Avg. Volume25,200
30 Day Avg. Volume17,598
Financial Highlights & Ratios
PEG Ratio-0.06
Price to Book (P/B)-0.42
Price to Sales (P/S)0.00
P/FCF Ratio-4.15
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
CENTR Brands Business Overview & Revenue Model
Company Description
CENTR Brands Corp. engages in the development and marketing of beverages infused with hemp-derived extracts and derivatives in the United States. The company offers CENTR, a sparkling, low-calorie, cannabidiol infused beverage; and CENTR Instant, ...
How the Company Makes Money
CENTR Brands primarily makes money by selling its branded beverages through wholesale and retail distribution as well as direct-to-consumer online sales where available. Revenue is generated from the sale of finished beverage products (e.g., ready...
CENTR Brands Financial Statement Overview
Summary
Income Statement
8
Very Negative
Balance Sheet
6
Very Negative
Cash Flow
10
Very Negative
| Breakdown | TTM | Aug 2025 | Aug 2024 | Aug 2023 | Aug 2022 | Aug 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 0.00 | 0.00 | 0.00 | 859.23K | 1.85M | 762.55K |
| Gross Profit | 0.00 | 0.00 | 0.00 | -482.81K | 533.40K | 156.44K |
| EBITDA | -185.19K | -401.54K | -595.08K | -2.04M | -6.68M | -7.55M |
| Net Income | -224.15K | -315.35K | -2.36M | -7.15M | 484.94K | -14.26M |
Balance Sheet | ||||||
| Total Assets | 82.27K | 12.90K | 48.96K | 3.64M | 5.89M | 2.38M |
| Cash, Cash Equivalents and Short-Term Investments | 49.29K | 1.31K | 36.19K | 2.44M | 3.86M | 832.05K |
| Total Debt | 352.28K | 113.94K | 29.32K | 706.28K | 942.98K | 39.39K |
| Total Liabilities | 1.85M | 1.25M | 984.78K | 2.72M | 1.79M | 6.01M |
| Stockholders Equity | -1.77M | -1.24M | -935.82K | 924.02K | 4.09M | -3.63M |
Cash Flow | ||||||
| Free Cash Flow | -112.39K | -125.51K | -605.38K | -4.99M | -5.59M | -4.20M |
| Operating Cash Flow | -112.39K | -125.51K | -603.78K | -4.98M | -5.57M | -4.19M |
| Investing Cash Flow | 0.00 | 0.00 | -2.18K | -6.30K | -23.68K | -9.04K |
| Financing Cash Flow | 179.08K | 90.91K | -64.07K | 3.57M | 8.62M | 4.52M |
CENTR Brands Technical Analysis
Neutral
0.02
Price Trends
0.05
Positive
0.03
Positive
0.03
Positive
Market Momentum
<0.01
Negative
46.18
Neutral
72.22
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:CNTR, the sentiment is Neutral. The current price of 0.02 is below the 20-day moving average (MA) of 0.05, below the 50-day MA of 0.05, and below the 200-day MA of 0.03, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 46.18 is Neutral, neither overbought nor oversold. The STOCH value of 72.22 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for TSE:CNTR.
CENTR Brands Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
44 Neutral | C$578.99K | -1.33 | 6.61% | ― | ― | ― | |
44 Neutral | C$563.53K | -0.24 | ― | ― | -74.95% | -13.64% | |
41 Neutral | C$258.28K | -1.17 | 5.70% | ― | ― | -406.12% | |
| ― | C$420.72K | -0.31 | ― | ― | ― | ― |
* Consumer Defensive Sector Average
TSE:CNTR
CENTR Brands
0.05
0.00
0.00%
TSE:MLCL
Molecule Holdings
0.01
0.00
0.00%
TSE:LRDS
Lords & Company Worldwide Holdings Inc
0.02
0.00
0.00%
TSE:XCX
Greenrise Global Brands Inc
0.01
-0.01
-50.00%
TSE:MJRX
Global Health Clinics
0.06
0.05
300.00%
TSE:XBRA
Xebra Brands Ltd.
0.01
-0.03
-75.00%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.